Skip to content
Screener

Phibro Animal Health PAHC Vaccines — Revenue

Other product segments

Medicated Feed Additives And Others
$205.79M+13.3%
Mineral Nutrition
$73.42M+9.9%
Nutritional Specialties
$46.81M+8.0%
Performance Products
$18.9M-16.6%

Similar metrics at other companies

Zoetis logo
ZTSVaccines — Revenue
$521M+2.2%
Lennar logo
LENOther revenues — Revenue
$331.4M-6.8%
PROG Holdings logo
PRGOther Revenues — Revenue
$21.62M+165%
Oracle logo
ORCLCloud Revenues — Revenue
$9.91B+47.1%
Oracle logo
ORCLSoftware Revenues — Revenue
$6.82B-2.1%
Blue Owl Capital logo
OWLPerformance revenues — Revenue
$6.07M-3.9%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.44B+20.2%
Enterprise value$1.42B+19.2%
P/E15.1×-9.7×
P/S1×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:25 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056280
For the Periods Ended March 31Three Months / 2026Three Months / 2025Nine Months / 2026Nine Months / 2025
Animal Health
MFAs and other$205,789$181,645$603,098$439,827
Nutritional specialties46,81043,350145,191131,908
Vaccines38,62633,382116,36998,583
Total Animal Health$291,225$258,377$864,658$670,318
Mineral Nutrition73,41866,774205,351189,086
Performance Products18,90022,67451,33758,114
Total$383,543$347,825$1,121,346$917,518

Item 1. Financial Statements (unaudited)

FAQ

What is Phibro Animal Health's vaccines — revenue?
Phibro Animal Health (PAHC) reported vaccines — revenue of $38.63M in Q1 2026.
How has Phibro Animal Health's vaccines — revenue changed year-over-year?
Phibro Animal Health's vaccines — revenue increased by 15.7% year-over-year, from $33.38M to $38.63M.
What is the long-term trend for Phibro Animal Health's vaccines — revenue?
Over 3 years (2022 to 2025), Phibro Animal Health's vaccines — revenue has grown at a 15.8% compound annual growth rate (CAGR), from $88.32M to $137.15M.
What does vaccines — revenue mean?
This metric represents the total net sales generated from the sale of vaccine products to customers, excluding any collected sales taxes. It serves as a primary indicator of the market demand and commercial success of the company's vaccine portfolio within the animal health segment. Growth in this figure reflects successful product adoption, pricing power, or expansion in the addressable animal health market.

Ask your AI about Phibro Animal Health's vaccines — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude